Asst Fatebenefratelli Sacco (Fatebenefratelli)

Milan, Lombardy 20121

0 studies enrolling now · 2 studies all time

What they study most

Crohn Disease

Studies at this site

• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed